GE Healthcare completes acquisition of Whatman plc
GE Healthcare, a unit of General Electric Company announced that it has completed the acquisition of Whatman plc, a global supplier of filtration products and technologies.
The acquisition expands GE Healthcare's offering for life science research and biopharmaceutical manufacturing. GE Healthcare's Life Sciences business is a world-class provider of technologies for cellular and protein science research, and tools used in the manufacture of biopharmaceuticals such as vaccines, cell therapies and antibodies. The addition of Whatman's innovative filters and membranes for laboratory research, life sciences and medical technology applications shall offer substantial customer benefits and create significant synergies through complementary product and service offerings.
Commenting on the close, Peter Ehrenheim President and CEO of GE Healthcare's Life Sciences business said: "Whatman's expertise and reputation in filtration technologies and sample preparation is a great fit for our Life Sciences business. We believe that combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical and drug discovery research."
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
FIBRETHERM by C. Gerhardt
Automatic Fibre Extraction for Feed Analysis
FIBRETHERM from C. Gerhardt: Efficient – Precise – Method-Compliant
Mini-UniPrep™ by Cytiva
Improved HPLC sample preparation
Save 66% sample preparation time and reduce costs by 40%
VICI Jour Katalog 15INT by VICI
The VICI Jour Catalog - Accessories for (U)HPLC and Liquid Handling
Capillaries, Tubing, Fittings, Filters, Safety-Products, Tools and much more
Hahnemühle LifeScience Catalogue Industry & Laboratory by Hahnemühle
Wide variety of Filter Papers for all Laboratory and Industrial Applications
Filtration Solutions in the Life Sciences, Chemical and Pharmaceutical Sectors
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous